|
FDA Slaps Validus With Untitled Letter for False Website Claims on Equetro
The FDA issued an untitled letter to Validus Pharmaceuticals claiming the drugmaker’s website published misleading claims for its bipolar disorder drug Equetro.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives